Atlas Trials

Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma

Clinical trial NCT03168035 · COMPLETED

Trial details

NCT number
NCT03168035
Sponsor
NanoCarrier Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced CancerLymphoma
Start date
2013-11-01
Primary completion
2017-04-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.